Brain Disease Modalities And Software Market Size is valued at 14.61 Billion in 2024 and is predicted to reach 24.53 Billion by the year 2034 at a 5.4% CAGR during the forecast period for 2025-2034.
Brain disease modalities are medical imaging techniques that are used to diagnose and monitor brain diseases. Brain disease software is used to analyze the images that are produced by brain disease modalities. Brain disease software can be used to identify and measure abnormalities in the brain, to track changes over time, and to plan treatment.
Conventional imaging methods for diagnosing brain disorders include MRI, CT scans, PET, and a combination of PET and MRI or CT features. While a magnetic field and radio waves are used in magnetic resonance imaging (MRI), a computerised tomography scan (CT) produces multi-angular cross-sectional X-ray images. These imaging methods are utilised to monitor vital processes such as brain oxygenation capacity, blood pressure, traumatic cranial injury, strokes, tumours, and neural activity.
The combined advancements in brain disease modalities and software have transformed the neurological diagnosis and treatment landscape. Through improved imaging technologies and sophisticated software tools, medical professionals can identify brain diseases at earlier stages, understand their underlying mechanisms better, and tailor treatment plans for individual patients. Continued research and integration of emerging technologies promise to drive further progress in neurology and offer new hope for patients with brain disorders.
The medical field's AI advancements, rising demand for safe medical imaging devices during surgeries, and increasing prevalence of neurological disorders are significant market drivers. However, the lack of affordability of non-invasive imaging devices hampers market growth in developing economies like Latin America, the Middle East, and Africa. Consequently, the low- and middle-income populations rely on alternative preliminary methods like blood biomarker tests and cognitive scoring tests for neurological disorder diagnosis. Globally, the shortage of Helium gas adversely affects medical imaging as it is essential for cooling down imaging devices after testing, directly impacting their functionality. Despite a decline in the demand for neuroimaging services, there has been a compensatory need for respiratory imaging techniques and COVID-19 treatment tests.
Brain disease modalities and software market are segmented into three main categories: Patients, Products and End-Users. First Patient Type is again subcategories in Adults, Paediatrics and Infants. Secondly, End-Users are subdivided into Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Imaging Centers. The last and third segment is by Products in that Brain Imaging Modalities and Brain Analysis Software are two subdivisions. There are five types of brain imaging modalities PET devices, CT devices, MRI devices, PET-CT, PET-MRI.
Almost all the regions are covered under the global brain disease modalities and software market consisting North America, Europe, Asia-Pacific and rest of the world. Besides North America and Europe being the largest market, other developing countries expect strong growth shortly.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 14.61 Billion |
|
Revenue Forecast In 2034 |
USD 24.53 Billion |
|
Growth Rate CAGR |
CAGR of 5.4% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Type of Patients, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
United Imaging Healthcare, Koninklijke Philips N.V., General Electric Company, Canon Inc., Siemens Healthineers AG, Vuno Co., Ltd., Fujifilm Holdings Corporation, Aspect Imaging, IXICO, QMENTA, Cortechs.ai, Quantib, Brainomix, Qure.AI, Imaging Biometrics and A.I., and Analysis, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Brain disease modalities and software Market Snapshot
Chapter 4. Global Brain disease modalities and software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Brain analysis software
5.2.1.1. PET Devices
5.2.1.2. CT Devices
5.2.1.3. MRI Devices
5.2.1.4. PET-CT
5.2.1.5. PET-MRI
5.2.2. Brain imaging modalities
Chapter 6. Market Segmentation 2: By Type of Patients Estimates & Trend Analysis
6.1. By Products & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Patients:
6.2.1. Adults
6.2.2. Pediatrics
6.2.3. Infants
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By Products & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
7.2.1. Hospitals and clinics
7.2.2. Ambulatory surgery centers
7.2.3. Diagnostic imaging centers
Chapter 8. Brain disease modalities and software Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
8.1.2. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.1.3. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.1.4. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Brain disease modalities and software Market revenue (US$ Million) By Products, 2021-2034
8.2.2. Europe Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.2.3. Europe Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User 2021-2034
8.2.4. Europe Brain disease modalities and software Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) By Products, 2021-2034
8.3.2. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.3.3. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.3.4. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Brain disease modalities and software Market revenue (US$ Million) By Products, 2021-2034
8.4.2. Latin America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.4.3. Latin America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.4.4. Latin America Brain disease modalities and software Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) By Products, (US$ Million)
8.5.2. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.5.3. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.5.4. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) by country, (US$ Million) 2021-2034South Africa
8.5.4.1. GCC Countries
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Quantib
9.2.2. Brainomix
9.2.3. Qure.AI
9.2.4. General Electric Company
9.2.5. Imaging Biometrics, LLC
9.2.6. United Imaging Healthcare Co. Ltd.
9.2.7. Siemens
9.2.8. Healthineers AG
9.2.9. Koninklijke Philips N.V.
9.2.10. Canon Inc.
9.2.11. Vuno Co. Ltd.
9.2.12. Aspect Imaging
9.2.13. IXICO
9.2.14. QMENTA
9.2.15. Cortechs.ai
9.2.16. A.I. Analysis Inc.
9.2.17. Fujifilm Holdings Corporation
9.2.18. Other Prominent Players.
Global Brain disease modalities and software Market by Products, 2032-2031 (Value US$ Mn)
Global Brain disease modalities and software Market by Type of Patients, 2024-2034 (Value US$ Mn)
Global Brain disease modalities and software Market by End-User, 2024-2034 (Value US$ Mn)
Global Brain disease modalities and software Market by Region, 2024-2034 (Value US$ Mn)
North America Brain disease modalities and software Market, by Country, 2024-2034 (Value US$ Mn)
Europe Brain disease modalities and software Market, by Country, 2024-2034 (Value US$ Mn)
Asia-Pacific Brain disease modalities and software Market arket, by Country, 2024-2034 (Value US$ Mn)
Latin America Brain disease modalities and software Market, by Country, 2024-2034 (Value US$ Mn)
Middle East & Africa Brain disease modalities and software Market, by Country, 2024-2034 (Value US$ Mn)
Competitive Landscape
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
